Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-174315
Filing Date
2024-07-02
Accepted
2024-07-02 16:06:04
Documents
10
Effectiveness Date
2024-07-02

Document Format Files

Seq Description Document Type Size
1 S-8 d801244ds8.htm S-8 55172
2 EX-4.1 d801244dex41.htm EX-4.1 77093
3 EX-5.1 d801244dex51.htm EX-5.1 11506
4 EX-23.1 d801244dex231.htm EX-23.1 1847
5 EX-23.2 d801244dex232.htm EX-23.2 1936
6 EX-99.1 d801244dex991.htm EX-99.1 54176
7 EX-99.2 d801244dex992.htm EX-99.2 54669
8 EX-FILING FEES d801244dexfilingfees.htm EX-FILING FEES 19050
9 GRAPHIC g801244dsp24.jpg GRAPHIC 4303
10 GRAPHIC g801244g0701203420260.jpg GRAPHIC 3797
  Complete submission text file 0001193125-24-174315.txt   287965
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280657 | Film No.: 241095146
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)